Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
Shai Shen-Orr, Professor at Technion – Israel Institute of Technology, shared on LinkedIn:
”For years I’ve been starting many of my talks, with imagining a world in which the question “Hey doc, how’s my immune system doing?” is a legit question.
Until now, medicine hasn’t had a good answer.
But we have reached a moment of singularity, where the tools to measure the human immune system are in place, as is the AI infrastructure, and most importantly, public awareness of the importance of understanding human immunology and human immune variation.
I’m so excited to share that the Human Immunome Project (HIP) has launched its Scientific Partner Network—the largest global collaboration in human systems immunology in history.
HIP is a bold, global infrastructure project: together we’re building the first comprehensive map of human immune diversity and function.
From this foundation, a thousand ships can launch—new diagnostics, predictive tools, and therapies that shift medicine toward prevention and true precision.
I’m honored to serve as Co-Chief Science Officer, alongside my good friend John Tsang, in the company of extraordinary partners worldwide.
This is a an effort powered by open science and collective vision. Deep gratitude to Jane Metcalfe, our chairwoman, the HIP Board, and all of our partners for their commitment and leadership.
Our founding network includes Yale University Center for Systems and Engineering Immunology, Technion – Israel Institute of Technology, Allen Institute for Immunology, Human Functional Genomics Project, HypoVax Global, RIKEN Research Center for Allergy and Immunology, Center for Human Immunology at Stanford University School of Medicine, Sustainable Sciences Institute, WEHI (Walter and Eliza Hall Institute of Medical Research), the German Center for Neurodegenerative Diseases (DZNE) and the Swarm Learning Consortium.
Together, we’re working to make “How’s my immune system doing?” a question medicine can finally answer—with high-resolution, tailored immune reference ranges, predictive risk models, and preventive strategies to keep people healthier, longer.
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology